Single Point Partners, LLC Merck & Co., Inc. Transaction History

Single Point Partners, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$113.24 - $131.95 $172,577 - $201,091	1,524 New	1,524 $201,000
Q2 2023 Jul 10, 2023	BUY	$108.61 - $118.38 $90,580 - $98,728	834 Added 12.87%	7,316 $844,000
Q1 2023 Apr 06, 2023	BUY	$102.94 - $114.86 $205 - $229	2 Added 0.03%	6,482 $690,000
Q4 2022 Jan 10, 2023	SELL	$87.44 - $112.11 $10,667 - $13,677	-122 Reduced 1.85%	6,480 $719,000
Q3 2022 Oct 07, 2022	SELL	$84.53 - $94.96 $10,228 - $11,490	-121 Reduced 1.8%	6,602 $569,000
Q2 2022 Jul 29, 2022	SELL	$83.49 - $94.64 $43,080 - $48,834	-516 Reduced 7.13%	6,723 $613,000
Q1 2022 Apr 28, 2022	BUY	$73.51 - $82.4 $265,150 - $297,216	3,607 Added 99.31%	7,239 $594,000
Q4 2021 Jan 27, 2022	SELL	$72.28 - $90.54 $66,063 - $82,753	-914 Reduced 20.11%	3,632 $278,000
Q3 2021 Oct 25, 2021	BUY	$71.68 - $78.83 $7,741 - $8,513	108 Added 2.43%	4,546 $341,000
Q2 2021 Jul 28, 2021	BUY	$70.31 - $77.77 $8,718 - $9,643	124 Added 2.87%	4,438 $348,000
Q1 2021 Apr 30, 2021	BUY	$68.86 - $81.11 $80,153 - $94,412	1,164 Added 36.95%	4,314 $333,000
Q4 2020 Jan 12, 2021	SELL	$71.77 - $79.65 $17,942 - $19,912	-250 Reduced 7.35%	3,150 $258,000
Q3 2020 Oct 30, 2020	SELL	$73.18 - $82.95 $5,854 - $6,636	-80 Reduced 2.3%	3,400 $282,000
Q2 2020 Jul 30, 2020	SELL	$70.42 - $80.13 $4,929 - $5,609	-70 Reduced 1.97%	3,480 $269,000
Q1 2020 Apr 17, 2020	BUY	$63.36 - $87.82 $67,288 - $93,264	1,062 Added 42.68%	3,550 $275,000
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $193,019 - $217,799	2,488 New	2,488 $226,000

3,831

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $284B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Single Point Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Single Point Partners, LLC with notifications on news.